| Jacalyn Dawn Bubier, OTR/L | |
|
10 May St, Biddeford, ME 04005-2923 | |
| (207) 282-4138 | |
| (207) 282-8242 |
| Full Name | Jacalyn Dawn Bubier |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 10 May St, Biddeford, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003142134 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 939 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacalyn Dawn Bubier, OTR/L 10 May St, Biddeford, ME 04005-2923 Ph: (207) 282-4138 | Jacalyn Dawn Bubier, OTR/L 10 May St, Biddeford, ME 04005-2923 Ph: (207) 282-4138 |
News Archive
A pregnant woman's immune response to viral infections may induce subtle neurological changes in the unborn child that can lead to an increased risk for neurodevelopmental disorders including schizophrenia and autism. Research published in the online journal mBio- provides new insights into how this may happen and suggests potential strategies for reducing this risk.
Wolters Kluwer Health today announced a joint venture with leading China drug information provider Medicom to deliver clinical decision support to doctors in China as the country prepares for significant changes to its healthcare system.
The association between television viewing and childhood obesity is directly related to children's exposure to commercials that advertise unhealthy foods, according to a new UCLA School of Public Health study published in the American Journal of Public Health.
From a virus's point of view, invading our cells is a matter of survival. The virus makes a living by highjacking cellular processes to produce more of the proteins that make it up.
Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).
› Verified 7 days ago
Suzanne Marie Normand, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7754 | |
Nancy E Berube, OTR/L, CBIS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Jordyn Lindsay Alvarez, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 407 Pool St, Biddeford, ME 04005 Phone: 207-282-5171 | |
Emma Chabot, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 407 Pool St, Biddeford, ME 04005 Phone: 207-282-5171 | |
Nina C Eriksen-o'malley, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 407 Pool St, #9716, Biddeford, ME 04005 Phone: 207-282-5171 | |
Laureen Sirois, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 62 West St, Biddeford, ME 04005 Phone: 207-282-4134 |